創新藥物
創新藥板塊聚焦原創藥物從靶點發現到臨床轉化與商業化全鏈條。核心賽道涵蓋小分子、單抗/雙抗與ADC、細胞與基因治療、核酸藥物及CRO/CMO。該板塊總市值為 1789.61 billion HKD，24h 漲跌幅 -0.92%，40 檔中，9 檔上漲 (22.50%)，30 檔下跌 (75.00%)。領漲個股為 樂普生物－Ｂ (02157)，24h 漲幅為 +5.63%。漲跌家數參差，板塊回落，但龍頭股表現相對優異。保持選擇性：圍繞臨床或政策催化事件操作；偏好現金充裕、處於後期臨床階段的研發管線，並在走弱時逢低加碼，因利率與給付/報銷訊號將影響估值。
名稱 | 最新價 | 漲跌幅 | 最新價 / 漲跌幅 | 走勢圖 | 價格區間 | 操作 |
|---|---|---|---|---|---|---|
 金斯瑞生物科技01548 | HK$16.76$69.09 | -0.35%-$0.24 | HK$16.76 -0.35% | $67.60$69.38 | ||
 石藥集團01093 | HK$8.36$34.46 | +0.72%+$0.24 | HK$8.36 +0.72% | $34.17$35.53 | ||
 康諾亞－Ｂ02162 | HK$78.55$323.82 | -4.55%-$15.45 | HK$78.55 -4.55% | $322.99$342.99 | ||
 信達生物－Ｂ01801 | HK$88.30$364.01 | -1.17%-$4.32 | HK$88.30 -1.17% | $364.01$371.43 | ||
 百濟神州06160 | HK$196.5$810.0 | -1.60%-$13.1 | HK$196.5 -1.60% | $810.0$826.1 | ||
 藥明康德02359 | HK$156.3$644.3 | -0.44%-$2.8 | HK$156.3 -0.44% | $644.3$658.7 | ||
 康方生物09926 | HK$95.65$394.31 | -2.99%-$12.16 | HK$95.65 -2.99% | $394.31$410.59 | ||
 藥明生物02269 | HK$38.42$158.38 | -0.62%-$0.98 | HK$38.42 -0.62% | $158.38$160.85 | ||
 晶泰控股02228 | HK$6.90$28.44 | -3.76%-$1.11 | HK$6.90 -3.76% | $28.44$29.97 | ||
 三生製藥01530 | HK$17.01$70.12 | -0.70%-$0.49 | HK$17.01 -0.70% | $69.83$70.98 | ||
 榮昌生物09995 | HK$83.80$345.46 | -2.15%-$7.62 | HK$83.80 -2.15% | $344.84$355.56 | ||
 中國生物製藥01177 | HK$5.05$20.81 | -0.78%-$0.16 | HK$5.05 -0.78% | $20.81$21.18 | ||
 樂普生物－Ｂ02157 | HK$4.68$19.29 | +5.40%+$0.98 | HK$4.68 +5.40% | $18.01$19.70 | ||
 翰森製藥03692 | HK$32.14$132.49 | -0.49%-$0.65 | HK$32.14 -0.49% | $132.16$134.80 | ||
 藥明合聯02268 | HK$53.25$219.52 | -2.02%-$4.53 | HK$53.25 -2.02% | $219.52$229.00 | ||
 科倫博泰生物－Ｂ06990 | HK$505.5$2,083.9 | -1.55%-$32.9 | HK$505.5 -1.55% | $2,083.9$2,127.2 | ||
 巨子生物02367 | HK$29.28$120.70 | +0.82%+$0.98 | HK$29.28 +0.82% | $119.63$122.35 | ||
 恒瑞醫藥01276 | HK$56.95$234.77 | -0.17%-$0.41 | HK$56.95 -0.17% | $233.74$237.66 | ||
 康哲藥業00867 | HK$11.98$49.38 | -0.33%-$0.16 | HK$11.98 -0.33% | $49.38$50.12 | ||
 ZAI LAB09688 | HK$14.79$60.97 | -0.53%-$0.32 | HK$14.79 -0.53% | $60.64$61.91 |